{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:35:20Z","timestamp":1777667720129,"version":"3.51.4"},"reference-count":38,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T00:00:00Z","timestamp":1385337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Hum Exp Toxicol"],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>There is increasing evidence that herpes zoster (HZ) incidence rates among children and adults (aged &lt;60 years) with a history of natural varicella are influenced primarily by the frequency of exogenous exposures, while asymptomatic endogenous reactivations help to cap the rate at approximately 550 cases\/100,000 person-years when exogenous boosting becomes rare. The Antelope Valley Varicella Active Surveillance Project was funded by the Centers for Disease Control and Prevention in 1995 to monitor the effects of varicella vaccination in one of the three representative regions of the United States. The stability in the data collection and number of reporting sites under varicella surveillance from 1995\u20132002 and HZ surveillance during 2000\u20132001 and 2006\u20132007 contributed to the robustness of the discerned trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Varicella vaccination may be useful for leukemic children; however, the target population in the United States is all children. Since the varicella vaccine inoculates its recipients with live, attenuated varicella\u2013zoster virus (VZV), clinical varicella cases have dramatically declined. Declining exogenous exposures (boosts) from children shedding natural VZV have caused waning cell-mediated immunity. Thus, the protection provided by varicella vaccination is neither lifelong nor complete. Moreover, dramatic increases in the incidence of adult shingles cases have been observed since HZ was added to the surveillance in 2000. In 2013, this topic is still debated and remains controversial in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary:<\/jats:title>\n                    <jats:p>When the costs of the booster dose for varicella and the increased shingles recurrences are included, the universal varicella vaccination program is neither effective nor cost-effective.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0960327113512340","type":"journal-article","created":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T22:26:30Z","timestamp":1385418390000},"page":"886-893","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Vaccination to prevent varicella"],"prefix":"10.1177","volume":"33","author":[{"given":"GS","family":"Goldman","sequence":"first","affiliation":[{"name":"Independent Computer Scientist, Pearblossom, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PG","family":"King","sequence":"additional","affiliation":[{"name":"Facility Automation Management Engineering (FAME) Systems, Lake Hiawatha,\r        NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2013,11,25]]},"reference":[{"key":"bibr1-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.05.050"},{"key":"bibr2-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.11.020"},{"key":"bibr3-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181a90b16"},{"key":"bibr4-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510290057037"},{"key":"bibr5-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00459-6"},{"key":"bibr6-0960327113512340","unstructured":"Maupin T, Peterson C, Civen R, Mascola L. Varicella Active             Surveillance Project (VASP). 2000, 2001, 2006, 2007 Annual Summary. Antelope Valley , County of Los Angeles Department of             Health Services (LADHS), Acute Communicable Disease Control, Centers for Disease Control             and Prevention (CDC) Cooperative Agreement No. U66\/CCU911165-10 and 5U01             IP000020-02\/5U01 IP000020-04."},{"key":"bibr7-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1177\/003591576505800106"},{"key":"bibr8-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws370"},{"key":"bibr9-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(94)90132-5"},{"key":"bibr10-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1086\/430325"},{"key":"bibr11-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1086\/430328"},{"key":"bibr12-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir436"},{"key":"bibr13-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1080\/10915810591000659"},{"key":"bibr14-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181acf84f"},{"key":"bibr15-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430150071008"},{"key":"bibr16-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/148.2.200"},{"key":"bibr17-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.2.450"},{"key":"bibr18-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.08.023"},{"key":"bibr19-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70207-5"},{"key":"bibr20-0960327113512340","doi-asserted-by":"publisher","DOI":"10.11150\/kansenshogakuzasshi1970.69.908"},{"key":"bibr21-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09837-9"},{"key":"bibr22-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-5-68"},{"key":"bibr23-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa064040"},{"key":"bibr24-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1086\/522150"},{"key":"bibr25-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1086\/522155"},{"key":"bibr26-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000109287.97518.67"},{"key":"bibr27-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq052"},{"issue":"6","key":"bibr28-0960327113512340","first-page":"464","volume":"245","author":"Jumaan AO","year":"2001","journal-title":"N Engl J Med"},{"key":"bibr29-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.076"},{"key":"bibr30-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.07.010"},{"key":"bibr31-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021662"},{"key":"bibr32-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31819c1041"},{"key":"bibr33-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00458-4"},{"key":"bibr34-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1086\/522163"},{"key":"bibr35-0960327113512340","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.7.6.753"},{"key":"bibr36-0960327113512340","unstructured":"Centers for Disease Control and\n            Prevention, CDC Vaccines for Children Program (VFC).\n            \u201cPediatric\/VFC Vaccine Price List.\u201d Available at: http:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/\n            (accessed  18 July 2013)."},{"key":"bibr37-0960327113512340","unstructured":"Zhou F. Economic evaluation of the universal varicella vaccination             program in the US. Centers for Disease Control and Prevention, National Immunization             Program, Record of the Meeting of the Advisory Committee on Immunization Practices,             Atlanta, GA, June 29\u201330, 2005, p. 31. Available at:             http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/min-archive\/min-jun05.pdf             (accessed 03 June 2013)."},{"key":"bibr38-0960327113512340","unstructured":"Joint Committee on Vaccination and\n            Immunisation Statement on varicella and herpes zoster vaccines.\n            UK Government Web Archive 2009. Available\n            at: http:\/\/webarchive.nationalarchives.gov.uk\/20130107105354\/http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/@dh\/@ab\/documents\/digitalasset\/dh_114908.pdf\n            (accessed 18 July 2013)."}],"container-title":["Human &amp; Experimental Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0960327113512340","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0960327113512340","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0960327113512340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:47:41Z","timestamp":1777448861000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0960327113512340"}},"subtitle":["Goldman and King\u2019s response to Myers\u2019 interpretation of Varicella Active           Surveillance Project data"],"short-title":[],"issued":{"date-parts":[[2013,11,25]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1177\/0960327113512340"],"URL":"https:\/\/doi.org\/10.1177\/0960327113512340","relation":{},"ISSN":["0960-3271","1477-0903"],"issn-type":[{"value":"0960-3271","type":"print"},{"value":"1477-0903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,25]]}}}